KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Consolidated Net Income (2017 - 2025)

Amneal Pharmaceuticals has reported Consolidated Net Income over the past 9 years, most recently at $49.6 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $49.6 million for Q4 2025, up 339.0% from a year ago — trailing twelve months through Dec 2025 was $127.9 million (up 273.17% YoY), and the annual figure for FY2025 was $127.9 million, up 273.17%.
  • Consolidated Net Income for Q4 2025 was $49.6 million at Amneal Pharmaceuticals, up from $18.1 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for AMRX hit a ceiling of $49.6 million in Q4 2025 and a floor of -$240.1 million in Q2 2022.
  • Median Consolidated Net Income over the past 5 years was $4.7 million (2022), compared with a mean of -$11.5 million.
  • Peak annual rise in Consolidated Net Income hit 1148.41% in 2023, while the deepest fall reached 1483.18% in 2023.
  • Amneal Pharmaceuticals' Consolidated Net Income stood at -$20.4 million in 2021, then surged by 71.12% to -$5.9 million in 2022, then plummeted by 1483.18% to -$93.3 million in 2023, then surged by 77.78% to -$20.7 million in 2024, then skyrocketed by 339.0% to $49.6 million in 2025.
  • The last three reported values for Consolidated Net Income were $49.6 million (Q4 2025), $18.1 million (Q3 2025), and $35.6 million (Q2 2025) per Business Quant data.